> top > docs > PMC:7075884 > spans > 4817-6532 > annotations

PMC:7075884 / 4817-6532 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
230 1561-1564 Gene denotes C13 Gene:3229
231 1466-1469 Gene denotes C15 Gene:51316
232 747-750 Gene denotes C17 Gene:54360
233 740-743 Gene denotes C15 Gene:51316
234 733-736 Gene denotes C13 Gene:3229
235 762-766 Species denotes HCMV Tax:10359
236 972-976 Species denotes HCMV Tax:10359
237 1170-1174 Species denotes HCMV Tax:10359
238 1497-1501 Species denotes HCMV Tax:10359
239 1570-1574 Species denotes HCMV Tax:10359
240 1647-1651 Species denotes HCMV Tax:10359
241 716-731 Chemical denotes Ginkgolic Acids MESH:C112485
242 987-991 Chemical denotes BI-6 MESH:C118647
243 1091-1093 Chemical denotes GA MESH:C112485
244 1373-1375 Chemical denotes GA MESH:C112485
245 1490-1493 Chemical denotes GCV MESH:D015774
246 1558-1560 Chemical denotes GA MESH:C112485
247 1625-1631 Chemical denotes GA C17
248 910-918 Disease denotes infected MESH:D007239
249 1095-1110 Disease denotes Viral infection MESH:D001102
250 1379-1388 Disease denotes infection MESH:D007239
251 1516-1525 Disease denotes infection MESH:D007239
252 1579-1588 Disease denotes infection MESH:D007239
253 1656-1665 Disease denotes infection MESH:D007239
254 843-857 CellLine denotes human foreskin CVCL:3285
255 871-874 CellLine denotes HFF CVCL:3285
266 226-237 Species denotes HCMV strain Tax:10359
267 455-465 Chemical denotes MEM medium
268 539-549 Chemical denotes MEM medium
269 633-635 Chemical denotes GA MESH:C112485
270 21-29 Disease denotes toxicity MESH:D064420
271 212-220 Disease denotes infected MESH:D007239
272 400-408 Disease denotes toxicity MESH:D064420
273 621-629 Disease denotes toxicity MESH:D064420
274 44-49 CellLine denotes HEp-2 CVCL:1906
275 423-426 CellLine denotes HFF CVCL:3285

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T20 50-55 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T21 97-102 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T22 171-176 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T23 206-211 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T24 353-358 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T25 427-432 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T26 655-660 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T27 849-857 Body_part denotes foreskin http://purl.org/sig/ont/fma/fma19639
T28 858-869 Body_part denotes fibroblasts http://purl.org/sig/ont/fma/fma63877
T29 904-909 Body_part denotes cells http://purl.org/sig/ont/fma/fma68646
T30 935-939 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T31 1396-1400 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T32 1506-1510 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T33 1637-1641 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 97-102 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T2 353-358 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T3 655-660 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T25 1095-1110 Disease denotes Viral infection http://purl.obolibrary.org/obo/MONDO_0005108
T26 1101-1110 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T27 1379-1388 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T28 1516-1525 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T29 1579-1588 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T30 1656-1665 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T56 44-49 http://purl.obolibrary.org/obo/CLO_0003707 denotes HEp-2
T57 44-49 http://purl.obolibrary.org/obo/CLO_0050927 denotes HEp-2
T58 50-55 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T59 171-176 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T60 206-211 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T61 379-381 http://purl.obolibrary.org/obo/CLO_0053794 denotes 41
T62 423-426 http://purl.obolibrary.org/obo/CLO_0052986 denotes HFF
T63 427-432 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T64 608-616 http://purl.obolibrary.org/obo/CLO_0001658 denotes activity
T65 747-752 http://purl.obolibrary.org/obo/CLO_0002099 denotes C17:1
T66 770-771 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T67 826-827 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T68 843-848 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T69 849-869 http://purl.obolibrary.org/obo/CL_1001608 denotes foreskin fibroblasts
T70 871-874 http://purl.obolibrary.org/obo/CLO_0052986 denotes HFF
T71 904-909 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T72 935-939 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T73 996-997 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T74 1334-1335 http://purl.obolibrary.org/obo/CLO_0001021 denotes B
T75 1396-1400 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T76 1406-1411 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T77 1427-1430 http://purl.obolibrary.org/obo/CLO_0053478 denotes GFP
T78 1502-1505 http://purl.obolibrary.org/obo/CLO_0053478 denotes GFP
T79 1506-1510 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T80 1575-1578 http://purl.obolibrary.org/obo/CLO_0053478 denotes GFP
T81 1628-1633 http://purl.obolibrary.org/obo/CLO_0002099 denotes C17:1
T82 1637-1641 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T83 1652-1655 http://purl.obolibrary.org/obo/CLO_0053478 denotes GFP
T84 1668-1669 http://purl.obolibrary.org/obo/CLO_0001021 denotes B
T85 1708-1714 http://purl.obolibrary.org/obo/UBERON_0007688 denotes fields

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T111 0-2 Chemical denotes GA http://purl.obolibrary.org/obo/CHEBI_5206|http://purl.obolibrary.org/obo/CHEBI_73855|http://purl.obolibrary.org/obo/CHEBI_5354
T114 38-40 Chemical denotes GA http://purl.obolibrary.org/obo/CHEBI_5206|http://purl.obolibrary.org/obo/CHEBI_73855|http://purl.obolibrary.org/obo/CHEBI_5354
T117 372-374 Chemical denotes GA http://purl.obolibrary.org/obo/CHEBI_5206|http://purl.obolibrary.org/obo/CHEBI_73855|http://purl.obolibrary.org/obo/CHEBI_5354
T120 417-419 Chemical denotes GA http://purl.obolibrary.org/obo/CHEBI_5206|http://purl.obolibrary.org/obo/CHEBI_73855|http://purl.obolibrary.org/obo/CHEBI_5354
T123 633-635 Chemical denotes GA http://purl.obolibrary.org/obo/CHEBI_5206|http://purl.obolibrary.org/obo/CHEBI_73855|http://purl.obolibrary.org/obo/CHEBI_5354
T126 733-738 Chemical denotes C13:0 http://purl.obolibrary.org/obo/CHEBI_45919
T127 740-745 Chemical denotes C15:1 http://purl.obolibrary.org/obo/CHEBI_75088
T128 740-743 Chemical denotes C15 http://purl.obolibrary.org/obo/CHEBI_42504
T129 747-752 Chemical denotes C17:1 http://purl.obolibrary.org/obo/CHEBI_36001
T130 1019-1023 Chemical denotes drug http://purl.obolibrary.org/obo/CHEBI_23888
T131 1091-1093 Chemical denotes GA http://purl.obolibrary.org/obo/CHEBI_5206|http://purl.obolibrary.org/obo/CHEBI_73855|http://purl.obolibrary.org/obo/CHEBI_5354
T134 1373-1375 Chemical denotes GA http://purl.obolibrary.org/obo/CHEBI_5206|http://purl.obolibrary.org/obo/CHEBI_73855|http://purl.obolibrary.org/obo/CHEBI_5354
T137 1463-1465 Chemical denotes GA http://purl.obolibrary.org/obo/CHEBI_5206|http://purl.obolibrary.org/obo/CHEBI_73855|http://purl.obolibrary.org/obo/CHEBI_5354
T140 1466-1471 Chemical denotes C15:1 http://purl.obolibrary.org/obo/CHEBI_75088
T141 1466-1469 Chemical denotes C15 http://purl.obolibrary.org/obo/CHEBI_42504
T142 1558-1560 Chemical denotes GA http://purl.obolibrary.org/obo/CHEBI_5206|http://purl.obolibrary.org/obo/CHEBI_73855|http://purl.obolibrary.org/obo/CHEBI_5354
T145 1561-1566 Chemical denotes C13:0 http://purl.obolibrary.org/obo/CHEBI_45919
T146 1625-1627 Chemical denotes GA http://purl.obolibrary.org/obo/CHEBI_5206|http://purl.obolibrary.org/obo/CHEBI_73855|http://purl.obolibrary.org/obo/CHEBI_5354
T149 1628-1633 Chemical denotes C17:1 http://purl.obolibrary.org/obo/CHEBI_36001

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T22 814-823 http://purl.obolibrary.org/obo/GO_0009058 denotes formation
T23 1095-1110 http://purl.obolibrary.org/obo/GO_0016032 denotes Viral infection

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T35 0-16 Sentence denotes GA IC50 vs. EC50
T36 17-202 Sentence denotes The toxicity EC50 of GA on HEp-2 cells in MEM supplemented with 1% fetal bovine serum (FBS) was 27.63 ± 2.21 μM (Fig. S1A) or 63.5 ± 3.2 μM (Fig. S1B) on cells supplemented with 5% FBS.
T37 203-395 Sentence denotes In cells infected with HCMV strain CH19 and supplemented with 1% FBS, the 50% inhibitory concentration (IC50) was 6.83 ± 1.08 μM, and with 10% bovine serum, the IC50 of GA was 41 μM (Fig. 1A).
T38 396-576 Sentence denotes The toxicity EC50 of GA on HFF cells was 14.00 μM ± 0.1 in MEM medium supplemented with 1% FBS (Fig. S1C), and 137.04 μM ± 10.44 (Fig. S1D) in MEM medium supplemented with 10% FBS.
T39 577-706 Sentence denotes The results indicated that the activity and toxicity of GA is affected by the serum concentration in the medium (see discussion).
T40 707-1094 Sentence denotes Figure 1 Ginkgolic Acids (C13:0, C15:1, C17:1) inhibit HCMV in a dose-dependent manner and prevents plaque formation. (A) Monolayers of human foreskin fibroblasts (HFF) were inoculated with 50–100 cells infected with one of two cell-associated clinical isolates of HCMV (CH19 and BI-6) in a total of 4 wells per drug concentration followed by treatment with medium containing 0–10 µM GA.
T41 1095-1242 Sentence denotes Viral infection was allowed to progress for 7 days when the mean number of HCMV plaques per concentration was counted, and the IC50 was determined.
T42 1243-1715 Sentence denotes The effects of different concentrations of FBS and time delay on the IC50 are also shown. (B) Dose-dependent inhibitory effect of GA on infection by the cell-free virus strain PT30CMV-GFP. (C) Inhibitory effect of 10 µM GA C15:1 compared to 16 µM GCV on HCMV-GFP cell-free infection. (D) Inhibitory effect of 10 µM GA C13:0 on HCMV-GFP infection, and (E) Inhibitory effect of 10 µM GA C17:1 on cell-free HCMV-GFP infection. (B–E) representing average of 20 scanned fields.